Skip to main content
. 2018 Mar 8;10(1):31. doi: 10.3390/pharmaceutics10010031

Figure 4.

Figure 4

(A) Muscle and (B) brain concentrations of Creatine-13C 4 h after administration of CM-13C. Values represent the mean ± SEM. Creatine-13C content in muscle and brain samples from non-treated rats was below detection limits (0.5 μg/g tissue). n = 4 rats. ** p < 0.01, *** p < 0.001, **** p < 0.0001 compared to levels in non-treated group. BDL = below detection limit.